Injectional anthrax in heroin users, Europe, 2000-2012.
Matthias
M
Hanczaruk
Udo
U
Reischl
Thomas
T
Holzmann
Dimitrios
D
Frangoulidis
David M
DM
Wagner
Paul S
PS
Keim
Markus H
MH
Antwerpen
Hermann
H
Meyer
Gregor
G
Grass
D000881:Anthrax / Q000175:diagnosis / Q000453:epidemiology* / Q000209:etiology / Q000382:microbiology; D001408:Bacillus anthracis / Q000145:classification* / Q000235:genetics / Q000302:isolation & purification; D015373:Bacterial Typing Techniques; D004269:DNA, Bacterial / Q000145:classification* / Q000235:genetics; D005060:Europe / Q000453:epidemiology; D003932:Heroin / Q000008:administration & dosage*; D006801:Humans; D010802:Phylogeny; D020641:Polymorphism, Single Nucleotide; D019966:Substance-Related Disorders / Q000150:complications / Q000175:diagnosis / Q000453:epidemiology* / Q000382:microbiology
D004269:DNA, Bacterial; D003932:Heroin
Bacillus anthracis; Europe; Germany; Trans-Eurasian clade; anthrax; bacteria; heroin users; humans; injectional anthrax; phylogeny; single nucleotide polymorphism